Phase II Study of Chiauranib Capsule in Advanced or Unresectable Soft Tissue Sarcoma
Status:
Recruiting
Trial end date:
2024-08-02
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to explore the preliminary efficacy of Chiauranib monotherapy in
patients with advanced or unresectable soft tissue sarcoma who failed standard therapy, and
the safety of Chiauranib monotherapy in patients with advanced or unresectable soft tissue
sarcoma who failed standard therapy and the relationship between potential biomarkers and
preliminary efficacy.